individual patient TCR-transduced PBL
/ National Cancer Institute - Bethesda
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 02, 2025
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: National Cancer Institute (NCI) | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
April 01, 2025
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
(clinicaltrials.gov)
- P1 | N=86 | Not yet recruiting | Sponsor: National Cancer Institute (NCI)
New P1 trial • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Disorders • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
1 to 2
Of
2
Go to page
1